Background: The DASH diet is inversely associated with T2DM risk. Metabolic changes due to DASH adherence and their potential relationship with incident T2DM have not been described.

Objective: To determine metabolite clusters associated with adherence to a DASH-type diet in the Insulin Resistance Atherosclerosis Study (IRAS) cohort and explore if they predict 5-year T2DM incidence.

Methods: DASH adherence for 570 nondiabetic multi-ethnic participants aged 40-69 years was determined using a 10-point scale for 8 DASH food groups. Data for 88 metabolites (acylcarnitines, amino acids, bile acids, sterols, and fatty acids) were obtained at baseline. Metabolite clusters associated with a DASH-type diet were determined using partial least squares analysis (PLS). Multivariable-adjusted logistic regression was used to explore the associations between metabolite clusters and incident T2DM.

Results: A group of acylcarnitines loaded strongly on two components retained under PLS (Figure). Component 2 was inversely associated with incident T2DM (OR: 0.86; 95% CI 0.79-0.95) after adjustment for demographic and metabolic covariates. Component 1 was not associated with T2DM risk (OR: 0.97; 95% CI 0.87-1.10).

Conclusion: Adherence to a DASH-type diet may contribute to reduced T2DM risk in part through modulations in acylcarnitine physiology.


S. Yashpal: None. A.D. Liese: None. L.E. Wagenknecht: None. S.M. Haffner: None. L.W. Johnston: None. B. Boucher: None. R.P. Bazinet: None. M. Rewers: None. J.I. Rotter: None. S.M. Watkins: Stock/Shareholder; Self; Verso Biosciences, Inc. A. Hanley: None.


National Institutes of Health

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at